Improving Outcomes in OAB: New and Emerging Strategies to Reduce Symptom Burden and Treatment Adverse Effects (Archived CME/CE Monograph)
This educational activity will review efficacy, safety, and tolerability data for overactive bladder pharmacologic therapies, including a new β3-adrenoceptor agonist, and their relevance for counseling to improve treatment adherence.
Category
  • Urology
Format
  • Archive
  • Monograph
Credits
Improving Outcomes in OAB: New and Emerging Strategies to Reduce Symptom Burden and Treatment Adverse Effects (Archived CME/CE Webcast)
This educational activity will review the efficacy, safety, and tolerability data for overactive bladder pharmacologic therapies, including current and emerging β3-adrenoceptor agonists.
Category
  • Urology
Format
  • Archive
  • Webcast
Credits
Improving Outcomes in OAB: New and Emerging Strategies to Reduce Symptom Burden and Treatment Adverse Effects (Archived CME/CE Webcast)
This educational activity will review the efficacy, safety, and tolerability data for overactive bladder pharmacologic therapies, including current and emerging β3-adrenoceptor agonists.
Category
  • Urology
Format
  • Archive
  • Webcast
Credits
New Treatment Strategies and Considerations in OAB to Improve Patient Outcomes (Archived Online CME/CE Monograph)
This educational activity is based on the proceedings of several symposia on OAB that reviewed updates in the treatment of OAB, including clinical data on new and emerging treatments, and which highlighted some of the evidence on the increased risk of dementia associated with antimuscarinic use.
Category
  • Urology
Format
  • Archive
  • Monograph
Credits
New Treatment Strategies and Considerations in OAB to Improve Patient Outcomes (Archived CME/CE Webcast)
This educational activity is based on the proceedings of a symposium held in conjunction with the 95th Annual Meeting of the North Central Section of the American Urological Association on OAB that reviewed updates in the treatment of OAB, including clinical data on new and emerging treatments, and which highlighted some of the evidence on the increased risk of dementia associated with antimuscarinic use.
Category
  • Urology
Format
  • Archive
  • Webcast
Credits
New Treatment Strategies and Considerations in OAB to Improve Patient Outcomes (Archived CME/CE Webcast)
This educational activity is based on the proceedings of a symposium held in conjunction with the 2021 Annual Meeting of the American Urological Association on OAB that reviewed updates in the treatment of OAB, including clinical data on new and emerging treatments, and which highlighted some of the evidence on the increased risk of dementia associated with antimuscarinic use.
Category
  • Urology
Format
  • Archive
  • Webcast
Credits
Addressing Challenging Atypical Patients With OAB: Case Discussions (CME/CE Webcast)
This webcast, which captures the proceedings of a live CME/CE symposium held during North Central Section AUA 2023, delves into the latest insights and treatment strategies for overactive bladder.
Category
  • Urology
Format
  • Webcast
Credits
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 ANCC
  • 1.00 Participation
Case Discussions in OAB, BPH, and More: Managing the Complex Patient (CME/CE Symposium at AUA2024)
Earn up to 1.0 Credit at this CME/CE symposium - Saturday, May 4, 2024, in San Antonio, Texas
Category
  • Urology
Format
  • Symposium / Meeting
Credits
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 ANCC
  • 1.00 Participation
Event date May 4, 2024